Position in NVAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$175,136
+$23,798 QoQ
Shares Held
18,592
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#138
of 263 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. NVAX ranks #59 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in NVAX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,136 | 18,592 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $151,338 | 18,592 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $124,938 | 18,592 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $101,985 | 11,763 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $74,106 | 11,763 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $75,400 | 11,763 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $94,574 | 11,763 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $148,566 | 11,763 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $148,919 | 11,763 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $56,227 | 11,763 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $56,755 | 11,824 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $116,042 | 16,028 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $60,064 | 8,084 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $31,663 | 4,569 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $417,131 | 40,577 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $362,034 | 19,892 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $612,479 | 11,909 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,207,712 | 16,398 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,423,319 | 16,938 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,624,751 | 12,661 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,688,056 | 12,661 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $736,662 | 4,063 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $440,352 | 3,949 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $427,874 | 3,949 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $287,890 | 3,454 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||